Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28460828 | 1.00 | HTT (0.59) | HTTALDH1A1MAPK1L3MBTL1MAPT | |
| SCHEMBL8488876 | 1.00 | HTT (0.59) | HTTALDH1A1MAPK1L3MBTL1MAPT | |
| SCHEMBL905777 | 1.00 | HTT (0.59) | HTTALDH1A1MAPK1L3MBTL1MAPT | |
| SCHEMBL16197784 | 1.00 | HTT (0.59) | HTTALDH1A1MAPK1L3MBTL1MAPT | |
| SCHEMBL17004058 | 1.00 | HTT (0.59) | HTTALDH1A1MAPK1L3MBTL1MAPT | |
| SCHEMBL9814068 | 1.00 | HTT (0.59) | HTTALDH1A1MAPK1L3MBTL1MAPT | |
| SCHEMBL8491249 | 1.00 | HTT (0.59) | HTTALDH1A1MAPK1L3MBTL1MAPT | |
| SCHEMBL3335775 | 1.00 | HTT (0.59) | HTTALDH1A1MAPK1L3MBTL1MAPT | |
| SCHEMBL2932079 | 1.00 | HTT (0.59) | HTTALDH1A1MAPK1L3MBTL1MAPT | |
| Sebacic Acid SCHEMBL28606878 | 1.00 | HTT (0.59) | HTTALDH1A1MAPK1L3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0160726-B1 | CONTINUOUS PROCESS FOR PRODUCTION OF BUBBLE GUM | NABISCO BRANDS, Inc. (US) | 1988-04-20 | — | — | EP | claimed |
| EP-0160726-A1 | Continuous process for production of bubble gum | NABISCO BRANDS, Inc. (US) | 1985-11-13 | — | — | EP | claimed |
| EP-4368686-B1 | LUBRICITY IMPROVER COMPOSITION FOR FUEL OIL AND USE THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2026-05-27 | — | — | EP | disclosed |
| US-20250368926-A1 | CLEANING WET WIPE | DAIO PAPER CORPORATION (JP) | 2025-12-04 | — | — | US | disclosed |
| EP-4592432-A2 | ARNATAR COMPOUNDS AND METHODS FOR ENHANCED CELLULAR UPTAKE | Arnatar Therapeutics (US) | 2025-07-30 | — | — | EP | disclosed |
| US-12365847-B2 | Lubricity improver composition for fuel oil and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2025-07-22 | — | — | US | disclosed |
| EP-4444357-B1 | ARNATAR COMPOUNDS AND METHODS FOR ENHANCED CELLULAR UPTAKE | ARNATAR THERAPEUTICS INC (US) | 2025-05-21 | — | — | EP | disclosed |
| EP-4544907-A1 | CLEANING WET WIPE | Daio Paper Corporation (JP) | 2025-04-30 | — | — | EP | disclosed |
| US-12247047-B2 | Arnatar compounds and methods for enhanced cellular uptake | ARNATAR THERAPEUTICS, INC (US) | 2025-03-11 | — | — | US | disclosed |
| CN-119264205-A | ARNATAR compounds and methods for enhancing cellular uptake | 昂拓生物医药有限公司 | 2025-01-07 | — | — | CN | disclosed |
| US-20240417422-A1 | ARNATAR COMPOUNDS AND METHODS FOR ENHANCED CELLULAR UPTAKE | ARNATAR THERAPEUTICS INC (US) | 2024-12-19 | — | — | US | disclosed |
| CN-104781314-A | Hydrogel prodrugs | ASCENDIS PHARMA AS | 2015-07-15 | — | — | CN | disclosed |
| US-20150045427-A1 | Oxaspiro[2.5]Octane Derivatives and Analogs | ZAFGEN, INC. | 2015-02-12 | — | — | US | disclosed |
| US-5620762-A | MIXTURE FREE OF HALIDE SALT AND CONTAINING A POLYAMIDE, ACRYLONITRILE-BUTADIENE COPOLYMER, A PLASTICIZER, A STABILIZER, A CROSSLINKING AGENT AND A FILLER; LAP RESISTANCE TO THE FIBER-WORKING SURFACE | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1997-04-15 | — | — | US | disclosed |
| US-4661170-A | Method and composition for preserving aluminum surfaces | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1987-04-28 | — | — | US | disclosed |
| EP-0083484-B1 | 1,1-ALKANEDIOL DICARBOXYLATE LINKED ANTIBACTERIAL AGENTS | PFIZER INC. (US) | 1986-02-19 | — | — | EP | disclosed |
| US-4457924-A | PENICILLINS, OXAPENICILLINS, BETA-LACTAMASE INHIBITORS | PFIZER, INC. (US) | 1984-07-03 | — | — | US | disclosed |
| EP-0083484-A1 | 1,1-Alkanediol dicarboxylate linked antibacterial agents | PFIZER INC. (US) | 1983-07-13 | — | — | EP | disclosed |
| US-3976660-A | Pyrrolidine derivatives | E. R. SQUIBB & SONS, INC. (US) | 1976-08-24 | — | — | US | disclosed |
| US-3968198-A | IODINE ISOCYANATE | BRIDGESTONE TIRE COMPANY LIMITED (JA) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240417422-A1 | ARNATAR COMPOUNDS AND METHODS FOR ENHANCED CELLULAR UPTAKE | FUT6, ENGASE, B3GNT2 | HTT 1260/4885ALDH1A1 1369/4885MAPK1 3569/4885 |
| US-20150045427-A1 | Oxaspiro[2.5]Octane Derivatives and Analogs | OXER1, ACOX3, OXGR1 | HTT 2905/4885ALDH1A1 411/4885MAPK1 2693/4885 |
| US-12247047-B2 | Arnatar compounds and methods for enhanced cellular uptake | FUT6, ENGASE, B3GNT2 | HTT 1260/4885ALDH1A1 1369/4885MAPK1 3569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.